# Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection

> **NCT03146403** · PHASE2 · TERMINATED · sponsor: **Genocea Biosciences, Inc.** · enrollment: 33 (actual)

## Conditions studied

- Genital Herpes
- HSV-2 Infection

## Interventions

- **BIOLOGICAL:** GEN-003
- **BIOLOGICAL:** Matrix-M2
- **OTHER:** 0.9% normal saline

## Key facts

- **NCT ID:** NCT03146403
- **Lead sponsor:** Genocea Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-24
- **Primary completion:** 2017-12-22
- **Final completion:** 2018-06-11
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** 2017 business decision to cease GEN-003 spending.
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03146403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03146403, "Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03146403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*